| Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey J Pemán, E Cantón, G Quindós, E Eraso, J Alcoba, J Guinea, P Merino, ... Journal of Antimicrobial Chemotherapy 67 (5), 1181-1187, 2012 | 202 | 2012 |
| Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007) E Pérez-Trallero, JE Martín-Herrero, A Mazón, C García-Delafuente, ... Antimicrobial agents and chemotherapy 54 (7), 2953-2959, 2010 | 188 | 2010 |
| Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida … E Cantón, J Pemán, G Quindós, E Eraso, I Miranda-Zapico, M Álvarez, ... Antimicrobial agents and chemotherapy 55 (12), 5590-5596, 2011 | 181 | 2011 |
| Bacteriemias por Escherichia coli productor de betalactamasas de espectro extendido (BLEE): significación clínica y perspectivas actuales. AM García-Hernández, E García-Vázquez, A Hernández-Torres, J Ruiz, ... Revista española de quimioterapia 24 (2), 2011 | 166 | 2011 |
| Staphylococcus spp. en España: situación actual y evolución de la resistencia a antimicrobianos (1986-2006) Ó Cuevas, E Cercenado, MJ Goyanes, A Vindel, P Trincado, T Boquete, ... Enfermedades infecciosas y microbiologia clinica 26 (5), 269-277, 2008 | 114 | 2008 |
| Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey J Pemán, E Cantón, MJ Linares-Sicilia, EM Roselló, N Borrell, ... Journal of clinical microbiology 49 (12), 4158-4163, 2011 | 95 | 2011 |
| Quinolone Resistance Mutations in Streptococcus pneumoniae GyrA and ParC Proteins: Mechanistic Insights into Quinolone Action from Enzymatic Analysis … XS Pan, G Yague, LM Fisher Antimicrobial agents and chemotherapy 45 (11), 3140-3147, 2001 | 88 | 2001 |
| Acinetobacter baumanii multirresistente: situación clínica actual y nuevas perspectivas. AH Torres, EG Vázquez, G Yagüe, JG Gómez Revista Española de Quimioterapia 23 (1), 2010 | 82 | 2010 |
| Comparison of diagnostic sensitivities of three assays (Bartels enzyme immunoassay [EIA], Biotest EIA, and Binax NOW immunochromatographic test) for detection of Legionella … C Guerrero, CM Toldos, G Yagüe, C Ramírez, T Rodríguez, M Segovia Journal of Clinical Microbiology 42 (1), 467-468, 2004 | 82 | 2004 |
| The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 … J Oteo, M Perez-Vazquez, V Bautista, A Ortega, P Zamarrón, D Saez, ... Journal of Antimicrobial Chemotherapy 71 (12), 3392-3399, 2016 | 81 | 2016 |
| A study of air microbe levels in different areas of a hospital G Ortiz, G Yagüe, M Segovia, V Catalán Current microbiology 59, 53-58, 2009 | 78 | 2009 |
| Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne … A Espinel-Ingroff, M Alvarez-Fernandez, E Cantón, PL Carver, SCA Chen, ... Antimicrobial agents and chemotherapy 59 (11), 6725-6732, 2015 | 67 | 2015 |
| Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and … E Cantón, J Pemán, D Hervás, C Iñiguez, D Navarro, J Echeverría, ... Journal of clinical microbiology 50 (12), 3921-3926, 2012 | 62 | 2012 |
| Cleavable-Complex Formation by Wild-Type and Quinolone-Resistant Streptococcus pneumoniae Type II Topoisomerases Mediated by Gemifloxacin and Other … G Yague, JE Morris, XS Pan, KA Gould, LM Fisher Antimicrobial agents and chemotherapy 46 (2), 413-419, 2002 | 60 | 2002 |
| Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method E Cantón, J Pemán, C Iñiguez, D Hervás, JL Lopez-Hontangas, ... Journal of Clinical Microbiology 51 (8), 2691-2695, 2013 | 57 | 2013 |
| Multidrug and carbapenem-resistant Acinetobacter baumannii infections: factors associated with mortality A Hernández-Torres, E García-Vázquez, J Gómez, M Canteras, J Ruiz, ... Medicina clinica 138 (15), 650-655, 2012 | 42 | 2012 |
| Effectiveness of fosfomycin for the treatment of multidrug-resistant Escherichia coli bacteremic urinary tract infections: a randomized clinical trial J Sojo-Dorado, I López-Hernández, C Rosso-Fernandez, IM Morales, ... JAMA network open 5 (1), e2137277-e2137277, 2022 | 41 | 2022 |
| Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis S Cortes-Lara, E del Barrio-Tofiño, C López-Causapé, A Oliver, ... Clinical Microbiology and Infection 27 (11), 1631-1637, 2021 | 39 | 2021 |
| Infecciones nosocomiales por Pseudomonas aeruginosa multiresistente incluido carbapenémicos: factores predictivos y pronósticos. Estudio prospectivo 2016-2017 A Hernández, G Yagüe, EG Vázquez, M Simón, LM Parrado, M Canteras, ... Revista Española de Quimioterapia 31 (2), 123, 2018 | 39 | 2018 |
| Bacteraemia due to Escherichia coli producing extended-spectrum beta-lactamases (ESBL): clinical relevance and today's insights AM García-Hernández, E Garcia-Vazquez, A Hernández-Torres, J Ruiz, ... Revista espanola de quimioterapia: publicacion oficial de la Sociedad …, 2011 | 34 | 2011 |
